Emerson Electric (EMR)
Industrials · Industrial Automation and Engineering · NYSE
Emerson Electric is a global leader in industrial automation and software, empowering companies to optimize their operations through advanced engineering and digital solutions.
What Emerson Electric does
Emerson Electric is a global technology and engineering company providing innovative solutions for customers in industrial, commercial, and residential markets. Its business is focused on two primary platforms: Software and Systems, which includes control systems and software, and Test and Measurement, as well as a range of industrial automation technologies. The company emphasizes automation solutions to optimize production, process, and energy efficiency for its global customer base.
Themes: industrial automation, digital transformation, industrial software, energy efficiency, process optimization
Fundamentals
- Price$157.26 as of 2026-08-21 close
- Market cap$87.7B as of 2026-08-21
- 1-year return+20.9% 2025-08-21 close $130.09 → 2026-08-21 close $157.26
- P/E35.00 as of 2026-08-24
- Net margin+13.8% as of 2026-08-24
- Gross margin+53.2% as of 2026-08-24
- ROE+12.7% as of 2026-08-24
- Debt / equity0.64 as of 2026-08-24
- Revenue growth (YoY)+4.8% as of 2026-08-24
- Revenue CAGR (3y)+9.3% SEC XBRL
- Beta1.22 as of 2026-08-24
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +2.4%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How EMR compares in its sector
- price-to-earnings ratiomiddle range 357 covered Industrials peers, as of 2026-08-24
- net profit margintop 25% 457 covered Industrials peers, as of 2026-08-24
- operating margintop 25% 457 covered Industrials peers, as of 2026-08-24
- gross margintop 25% 455 covered Industrials peers, as of 2026-08-24
- return on equitymiddle range 460 covered Industrials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 426 covered Industrials peers
- indicated dividend yieldtop 25% 267 covered Industrials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 10% 414 covered Industrials peers, as of FY2025
Position among covered Industrials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
EMR is not currently in any published Top 10 list. Its scores are below.
Long-term score
56.6 #270 of 987 scored · #33 of 197 in Industrials
Capital return 71st (consecutive years of dividend increases 5 years) and long-term trend 69th (a strong uptrend, with buyers in control); weakest is valuation (34th, price to book 4.3, price to earnings 34.4).
Short-term score
52.7 #620 of 1,704 scored · #92 of 283 in Industrials
Trend 64th: a strong uptrend, with buyers in control; momentum 62nd: its RSI momentum gauge is in neutral territory; weakest is catalysts 34th: the analyst consensus rating has softened toward "sell" since the prior reading.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, EMR's dividend was covered by reported results (earnings payout 52%, free-cash-flow payout 45%). This describes past coverage, not a forecast.
- Earnings payout52% dividends / net income
- Free-cash-flow payout45% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Emerson Electric looks technically
Emerson Electric (EMR) is trading 11.1% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 56 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 32, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 3 trading days ago (its momentum flipped negative). It made a new 20-day high about 9 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 11.1% above its 200-day average, the long-term trend line — a longer-term uptrend | +11.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $147.77 | $147.77 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $141.51 | $141.51 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 9 calendar days ago — the swings before that are what the structure reading is measured on | 9 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 56 trading days ago — a "golden cross", a bullish long-term signal | 56 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 11.1% above | +11.1% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 32, with buyers in control | 32.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30) | 55.0 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($152.28 to $166.24) — its "stochastic" reading is 36 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 35.7 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 3 trading days ago (its momentum flipped negative) | 3 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $166.24 | $166.24 |
|---|---|---|
| From the 52-week high | it is 5.4% below its 52-week high (its highest price of the past year) | -5.4% |
| Above the 52-week low | it is 28.2% above its 52-week low (its lowest price of the past year) | +28.2% |
| Below the 52-week high | it is 5.4% below its highest point of the past year | 5.4% |
| Since a 20-day breakout | it made a new 20-day high about 9 trading days ago | 9 sessions |
| Since a 55-day breakout | it made a new 55-day high about 9 trading days ago | 9 sessions |
| All-time high | its highest closing price on record is $166.24 (set on 2026-08-12) | $166.24 |
| Given back of the 52-week move | over the past year its closes ranged ($123.30 to $164.38), and it has given back roughly a quarter of its rise from last year’s low — 17% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $137.68 to $138.99. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 17.3% |
| From the all-time high | it is 5.4% below its all-time high | -5.4% |
| Nearest price level | it is trading 5.0% above a support level at $149.37 — a price it turned at three times since 2025-07-29, most recently on 2026-05-06. Since 2024-08-21 it has 11 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -5.0% |
| All-time low | its lowest closing price on record is $20.25 (set on 2000-03-13) | $20.25 |
| Above the all-time low | it is 676.6% above its all-time low | +676.6% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 58th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $4.12 between its high and its low — about 2.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $4.12 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $146.06 and $167.97 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $146.06 – $157.02 – $167.97 |
| Typical daily range (% of price) | its price moves about 2.6% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.6% |
| Stretch from the 200-day average | it is trading 3.8 daily ranges above its 200-day average price (11.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.8 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.78× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.6% since the prior reading | +0.6% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating has softened toward "sell" since the prior reading | 0.03 toward sell |
Candlestick patterns
1
| Since a doji | 6 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 6 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 1.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +1.1% |
|---|---|---|
| Open gap | it gapped 2.4% above the previous close 16 sessions ago and has not traded back through the level it left behind at 145.73 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.4% |
| Gap filled | a 2.2% gap down opened on 2026-06-23 has been "filled" 19 sessions ago — price traded back through the level the gap left behind, and it took 23 sessions to close | 19 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 10.6 percentage points (the stock gained 12.9% while the market gained 2.3%) | +10.6% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 13.5 percentage points (the stock gained 16.6% while the market gained 3.1%) | +13.5% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 5.3 percentage points (the stock gained 5.8% while the market gained 11.1%) | -5.3% |
| vs market, 12 months | over the past 12 months this stock beat the market by 0.4 percentage points (the stock gained 20.9% while the market gained 20.5%) | +0.4% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 12% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thin, spanning 0.1% of the share price, which is taken to mean a barrier that gives way easily. | +11.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 9% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $144.56 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +8.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% below the average price paid since it last reported on 2026-08-04 (its 10-Q), so the typical buyer over that stretch is under water. That average is $160.11 — a volume-weighted average of daily closes over 14 sessions, not a true tick-by-tick VWAP. | -1.8% |
Price levels it has turned at before
EMR last closed at $157.26 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $149.37 | Support | 5.0% below the last close | turned there three times · 2025-07-29 to 2026-05-06 |
| $165.64 | Resistance | 5.3% above the last close | turned there twice · 2026-02-11 to 2026-08-12 |
| $145.12 | Support | 7.7% below the last close | turned there three times · 2026-01-30 to 2026-05-29 |
| $140.42 | Support | 10.7% below the last close | turned there three times · 2025-11-03 to 2026-04-16 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Tested and reclaimed 200-day support · MACD just crossed bearish (12/26/9) · in a strong, established uptrend (ADX) · lagging the market · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.97 mean, 1=Strong Buy…5=Strong Sell) — 27 analysts
- Mean price target$171.07 range $104.00 – $205.00; median $175.00
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for EMR
- Consensus EPS estimate$1.84 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Exposure to risks associated with international operations and global supply chain disruptions.","Intense competition in the industrial automation and software markets.","Dependence on global capital investment cycles and industrial demand."]
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days.
- Last 90 days0 buys · 1 sell ($2M) — 1 selling insider
- Last 180 days0 buys · 2 sells ($2M) — 2 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-01. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about EMR's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 11 matched disclosures for EMR from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding EMR as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 75,055,681
- Reported value $9,833,795,425
reported quarterly holdings change (2025-12-31 → 2026-03-31): 1 new, 3 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
EMR had 12,430,617 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
EMR had 2.23% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.24 days to cover at the same settlement.
- Reported short interest (shares) 12,430,617
- Short interest (% of shares outstanding) 2.23%
- Prior settlement (shares) 11,776,220
- Reported change 5.56%
- Days to cover (reported) 4.24
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Honeywell (HON)
- Schneider Electric
- Siemens
- Rockwell Automation (ROK)
- ABB
- Johnson Controls (JCI)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare EMR vs…
Emerson Electric is found in…
Frequently asked questions
What does Emerson Electric (EMR) do?
Emerson Electric is a global technology and engineering company providing innovative solutions for customers in industrial, commercial, and residential markets. Its business is focused on two primary platforms: Software and Systems, which includes control systems and software, and Test and Measurement, as well as a range of industrial automation technologies. The company emphasizes automation solutions to optimize production, process, and energy efficiency for its global customer base.
What sector is Emerson Electric (EMR) in?
Emerson Electric (EMR) is classified in the Industrials sector. Its industry is Industrial Automation and Engineering. It trades on NYSE.
Does EMR pay a dividend?
Yes — Emerson Electric (EMR) pays a dividend, with an indicated yield of about 2.37% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Emerson Electric's (EMR) competitors?
Notable peers of Emerson Electric (EMR) include Honeywell, Schneider Electric, Siemens, Rockwell Automation and ABB. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in EMR?
Yes — we hold 11 matched STOCK Act disclosures for EMR from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Emerson Electric (EMR) overbought or oversold right now?
Emerson Electric (EMR) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 55, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on EMR come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.